XJPX4350
Market cap74mUSD
Jan 17, Last price
396.00JPY
1D
0.76%
1Q
-7.48%
Jan 2017
-8.33%
IPO
237.02%
Name
Medical System Network Co Ltd
Chart & Performance
Profile
Medical System Network Co., Ltd. distributes pharmaceutical products for pharmacies, hospitals, clinics, and pharmaceutical wholesalers. The company operates through Community Pharmacy Network, Leasing and Facility-related, Meal Catering, and Other Segments. The Community Pharmacy Network segment facilitates purchase and sale of pharmaceuticals between pharmacies, hospitals, clinics, and pharmaceutical wholesalers. This segment also offers inventory management and inventory clearance services, as well as manufactures and markets pharmaceuticals, and involved in negotiating prices with pharmaceutical wholesalers. It operates pharmaceutical platform for transition of pharmacies. Its Leasing and Facility-related segment involves in building leasing services and develops locations for pharmacies, as well as offers consulting services for physicians. The company's Meal Catering segment provides meal catering services for hospitals and welfare facilities. In addition, the company offers nursing care and advisory counseling services for medical treatment. Medical System Network Co., Ltd. was founded in 1999 and is headquartered in Sapporo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 115,361,000 5.30% | 109,551,000 2.69% | 106,685,000 2.33% | |||||||
Cost of revenue | 67,435,000 | 63,629,000 | 62,256,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 47,926,000 | 45,922,000 | 44,429,000 | |||||||
NOPBT Margin | 41.54% | 41.92% | 41.65% | |||||||
Operating Taxes | 1,579,000 | 1,389,000 | 1,624,000 | |||||||
Tax Rate | 3.29% | 3.02% | 3.66% | |||||||
NOPAT | 46,347,000 | 44,533,000 | 42,805,000 | |||||||
Net income | 1,860,000 15.53% | 1,610,000 -32.75% | 2,394,000 8.92% | |||||||
Dividends | (365,000) | (395,000) | (304,000) | |||||||
Dividend yield | 1.83% | 3.27% | 1.84% | |||||||
Proceeds from repurchase of equity | (555,000) | |||||||||
BB yield | 2.78% | |||||||||
Debt | ||||||||||
Debt current | 6,116,000 | 6,377,000 | 5,935,000 | |||||||
Long-term debt | 28,223,000 | 28,261,000 | 24,534,000 | |||||||
Deferred revenue | (44,000) | (43,000) | ||||||||
Other long-term liabilities | 6,654,000 | 6,247,000 | 5,590,000 | |||||||
Net debt | 25,882,000 | 23,116,000 | 22,113,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 7,725,000 | 4,973,000 | 4,010,000 | |||||||
CAPEX | (2,110,000) | (1,607,000) | (2,128,000) | |||||||
Cash from investing activities | (3,649,000) | (2,114,000) | (2,511,000) | |||||||
Cash from financing activities | (3,944,000) | (2,918,000) | (3,415,000) | |||||||
FCF | 45,071,000 | 42,097,000 | 42,815,000 | |||||||
Balance | ||||||||||
Cash | 8,273,000 | 8,141,000 | 8,201,000 | |||||||
Long term investments | 184,000 | 3,381,000 | 155,000 | |||||||
Excess cash | 2,688,950 | 6,044,450 | 3,021,750 | |||||||
Stockholders' equity | 15,275,000 | 13,771,000 | 12,538,000 | |||||||
Invested Capital | 47,364,050 | 44,562,550 | 44,759,250 | |||||||
ROIC | 100.83% | 99.71% | 101.49% | |||||||
ROCE | 95.75% | 90.66% | 92.90% | |||||||
EV | ||||||||||
Common stock shares outstanding | 30,070 | 30,179 | 30,171 | |||||||
Price | 665.00 66.25% | 400.00 -26.87% | 547.00 -23.17% | |||||||
Market cap | 19,996,236 65.65% | 12,071,418 -26.86% | 16,503,505 -23.54% | |||||||
EV | 45,925,236 | 35,363,418 | 38,742,505 | |||||||
EBITDA | 51,089,000 | 48,879,000 | 47,284,000 | |||||||
EV/EBITDA | 0.90 | 0.72 | 0.82 | |||||||
Interest | 288,000 | 277,000 | 183,000 | |||||||
Interest/NOPBT | 0.60% | 0.60% | 0.41% |